Overview
Akira Koshino practices practicing medicine in Nagakute, Japan.
Their clinical expertise encompasses Chronic Idiopathic Constipation (CIC), Colorectal Cancer, and Hairy Cell Leukemia (HCL).
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Akira Koshino
Is Akira Koshino a top-rated expert for Chronic Idiopathic Constipation (CIC)?
MediFind is an objective health platform that identifies experts based on real-world data. Akira Koshino is classified as an Experienced expert for Chronic Idiopathic Constipation (CIC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Akira Koshino participate in research or clinical trials?
Yes. Akira Koshino has published 15 articles and abstracts on conditions like Chronic Idiopathic Constipation (CIC). You can view a list of Akira Koshino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Idiopathic Constipation (CIC)
- Colorectal CancerKoshino isExperienced. Learn about Colorectal Cancer.
- Hairy Cell Leukemia (HCL)Koshino isExperienced. Learn about Hairy Cell Leukemia (HCL).